Suzanne Greco

Suzanne Greco has a diverse range of work experience in the finance and consulting sectors. Suzanne is currently serving as the Vice President of Finance at Repertoire Immune Medicines since August 2021. Prior to this, they worked at Sanofi as an Investor Relations Officer from November 2018 to October 2021.

Before their time at Sanofi, Suzanne held the position of Head of Financial Planning & Analysis at Bioverativ, a biopharmaceutical company, from February 2017 to November 2018. Suzanne played a key role in the company's launch as a publicly traded entity and its subsequent acquisition by Sanofi.

Suzanne also has a long tenure at Biogen, where they served as the Director of Business Planning from January 2005 to February 2017. Suzanne'searly career includes positions at Investor Group Services (IGS) as a Consultant from September 2002 to January 2005, and at ARTHUR ANDERSEN as a Senior Associate in Tax Consulting from June 1996 to September 2000.

Throughout their career, Suzanne has demonstrated their expertise in finance, strategic planning, and market analysis, particularly in the healthcare and biopharmaceutical sectors.

Suzanne Greco obtained their Bachelor of Science degree in Accounting - Honors from Binghamton University, where they studied from 1993 to 1997. Suzanne went on to pursue further education at The Tuck School of Business at Dartmouth, where they earned their Master's in Business Administration (MBA) with a specialization in General Management. Suzanne attended The Tuck School of Business from 2000 to 2002.